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1. Introduction 2. Materials and methods 
It is well established that short term phenobarbital 
(PB) treatment results in a significant increase in both 
liver microsomal membranes and the enzymes partici- 
pating in hydroxylation reactions [I]. The underlying 
mechanism for this elevation in membrane constituents 
has been studied in detail by measuring the turnover of 
various microsomal proteins. It has been concluded 
from these studies that both increased synthesis and 
decreased breakdown occur [2,3]. This latter event is 
of great significance in the induction phenomenon 
since the breakdown of several electron transport 
enzymes, like NADPH-cytochrome c reductase and 
cytochrome b, , is completely abolished in the first 
eight days of the treatment [4]. Although reutilization 
of the labeled compound used in the turnover studies 
cannot be excluded completely [S], it does not appear 
sufficient to explain the experimental results indicating 
decreased catabolism [6]. 
Starved rats weighing 180-200 g were used. PB 
was injected intraperitoneally once a day (8 mg/lOO g 
body weight). [2-3H]Glycerol (50 mCi/mmole) and 
[2-3H]mevalonate (60 mCi/mmole), both from the 
Radiochemical Centre, Amersham, were diluted in 
sterile Ringers solution and injected intraperitoneally, 
20 &i in the case of rate incorporation (10 min) and 
40 $i in the case of half-life studies. In these latter 
experiments the livers from a series of rats were 
removed on the days that are indicated in the figures. 
Investigations regarding the PB-induced turnover of 
the lipid part of the membrane have been restricted to 
the use of [32P] orthophosphate [7,8], which has the 
disadvantage of being influenced by exchange reactions. 
In this paper the incorporation rate of [3H]glycerol into 
microsomal phospholipids (PLP) and [3H]mevalonate 
into cholesterol were studied, and the half-lives of 
these components were determined. The results show 
that lipid composition of the microsomal membranes 
remains unchanged after drug treatment. The 
mechanism by which PLP and cholesterol are main- 
tained in the membrane is complex as shown by the 
present studies. 
Microsomes and mitochondria were prepared as 
described previously [9]. PLP was extracted and 
separated from neutral lipids on a silicic acid column 
[IO]. Radioactivity in the methanol and chloroform 
phase were measured with a toluene scintillator [ 111. 
The radioactivity values of the phenobarbital treated 
rats was corrected for weight increase and recovery 
as described by Kuriyama et al. [4]. 
Protein, PLP and cholesterol were determined as 
earlier [ 121. 
All values represent the mean of four to nine 
experiments. 
3. Results and discussion 
The total microsomal fraction isolated after four 
days of PB treatment contains about twice as much 
protein, PLP and cholesterol as the microsomal frac- 
tion from livers of control rats (table 1). Because of 
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Table 1 
Chemical composition of total microsomal fraction after 
phenobarbital treatment. 
Protein PLP Chol. 




None 20.7 6.1 0.52 3.4 0.085 
36.4 10.4 0.81 3.5 0.078 4-days 
Chol. represents cholesterol. 
the parallel increase of all three components, the 
protein per PLP and the cholesterol per PLP ratios are 
unchanged. This distribution of the main membrane 
components is also found in all the other periods of 
incubation investigated. 
The initial linear phase of incorporation of 
[3Hjglycerol into the total PLP fraction and of the 
[3H~mevalonate into cholesterol exhibits two different 
patterns during PB induction (table 2). Incorporation of 
[“HIglycerol 10 min after the injection of label in- 
creases only 10% in the first 24 hr period and after the 
first day there is a continuous decrease in incorporation 
rate, being only one third of the control value after 
four days treatment. On the other hand [3H]mevalon- 
ate incorporation into cholesterol increases steadily 




















Fig. 1. Decay of specific radioactivity of [ 3H]glycerol in the phospholipid fractions. [3H]Glycerol incorporation was followed in 
the methanol fraction after silicic acid chromatograohy. a) Decay in control mitochondria (Mit), rough (R), smooth I (S 1) and 
smooth II (S II) microsomes. b) Decay in total microsomal fraction during phenobarbital treatment. Phenobarbital was injected 
once a day by giving the first injection at day one. 
352 
Volume 29, number 3 FEBS LETTERS February 1973 
Table 2 
Incorporation of [ 3H]glycerol and [ 3H] mevalonate into 
microsomal lipids after phenobarbital treatment. 
Incorporation rate 
PB treatment [3H]glycerol [ 3H] mevalonate 
(cpm/mg PLP) (cpm/mg choles- 
terol) 
None 405 120 
1 day 443 148 
4 days 131 202 
Injection was given as described in Materials and methods. 
Glycerol incorporation (10 min) was measured in the metha- 
nol phase after silicic acid chromatography, and mevalonate 
incorporation (10 min) was determined by following the 
radioactivity in the chloroform phase of the silicic acid 
chromatography. 
The decrease in specific activity of incorporated 
[3H]glycerol during the period of day 1 to day 14 
is shown in fig. la. The decay pattern is identical for 
mitochondria and the three microsomal subfractions: 
rough, smooth I and smooth II microsomes. The 
experiment indicates that the total microsomal frac- 
tion can be used in such an investigation and isolation 
of various subfractions does not give additional in- 
formation. The identical decay curve of the mito- 
chondrial fraction suggests that the protein carrier 
mediated lipid exchange process, which is demon- 
strated to occur under in vitro conditions [ 131, also 
takes place in vivo. There are two slopes, one with a 
graphically determined half-life of 16 hr and one with 
a much longer half-life, about 83 hr. The decay of 
radioactivity of the PLP is much slower when the rat 
is treated with PB during the whole period of investiga- 
tion (fig. lb). The half-lives calculated from the two 
slopes are 40 and 112 hr, respectively. The reason for 
the two slopes is not clear and cannot be explained 
exclusively by appearance of some label in the fatty 
acid moiety. After deacylation, the hydrophilic frac- 
tions still exhibit the two main features described 
above, i.e., two components with different turnover 
rates. Furthermore, both components decay more 
slowly in PB-treated rats. 
Similarly to PLP, cholesterol also displays two 
separate compartments as regards half-lives, one of 
24 hr and one of 141 hr (fig. 2). On the other hand, 
PB does not influence the decay slopes to any appre- 
x 
0 
Fig. 2. Decay of specific radioactivity of [3H]mevalonate in the 
neutral lipid fraction. The lipid extract from total microsomes 
was subjected to silicic acid chromatography and radioactivity 
was measured in the chloroform phase. In the phenobarbital 
(PB) experiments, PB was injected once a day by giving the 
first injection at day one. The values indicated in the figure 
concern control rat. Chol. represents cholesterol. 
ciable extent since the two values are 22 and 141 hr, 
respectively. 
It appears that the unchanged lipid composition 
of the liver microsomes isolated from PB-treated 
rats is maintained by a complex mechanism. Both 
PLP and cholesterol increase to a great extent, and 
in a parallel fashion, but the elevations are caused 
in different ways. The main reason for the increase 
of PLP appears to be a decreased breakdown paralleled 
by an unchanged or decreased rate of synthesis, 
while the elevation of membrane cholesterol occurs 
because of the increased rate of synthesis with no 
change in degradation. 
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